Management of transitional-cell carcinoma of the renal pelvis and ureter.
Swiss Med Wkly
; 139(25-26): 353-6, 2009 Jun 27.
Article
in En
| MEDLINE
| ID: mdl-19562529
ABSTRACT
Transitional-cell carcinoma of the renal pelvis or ureter is a relatively rare disease. Several risk factors are smoking, occupational carcinogens, analgesic abuse or Balkan nephropathy. The grade and stage of the disease have the most significant impact on the outcome. The treatment of renal pelvis and ureter tumours is open or laparoscopic surgery varying from conservative to more extensive surgical procedures, i.e. radical nephroureterectomy including removal of the contents of Gerota's fascia with ipsilateral ureter and a cuff of bladder at its distal extent. Most available data are from retrospective studies and surgery is the mainstay of treatment. Chemotherapy and/or radiation therapy are possible adjuvant or primary treatment for selected patients; however, prospective studies are needed to confirm their use.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ureteral Neoplasms
/
Carcinoma, Transitional Cell
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Swiss Med Wkly
Journal subject:
MEDICINA
Year:
2009
Type:
Article
Affiliation country:
Switzerland